Evidence map›Paper›PMID 36779498›Full record

ArticleMolecular pharmaceutics2023

Functional Characterization of Six

Katja Häkkinen, Wilma Kiander, Heidi Kidron, Markku Lähteenvuo, Lea Urpa, Jonne Lintunen, Kati-Sisko Vellonen, Seppo Auriola, Minna Holm, Kaisla Lahdensuo and 10 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 3 countries.

Katja HäkkinenDepartment of Forensic Psychiatry, Niuvanniemi Hospital, University of Eastern Finland, Kuopio FI-70240, Finland.ORCID 0000-0001-8222-7505
Wilma KianderDivision of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki FI-00014, Finland.
Heidi KidronDivision of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki FI-00014, Finland.ORCID 0000-0001-6427-8042
Markku LähteenvuoDepartment of Forensic Psychiatry, Niuvanniemi Hospital, University of Eastern Finland, Kuopio FI-70240, Finland.
Lea UrpaInstitute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki FI-00014, Finland.ORCID 0000-0002-8712-3518
Jonne LintunenDepartment of Forensic Psychiatry, Niuvanniemi Hospital, University of Eastern Finland, Kuopio FI-70240, Finland.ORCID 0000-0001-5627-2388
Kati-Sisko VellonenSchool of Pharmacy, University of Eastern Finland, Kuopio FI-70211, Finland.
Seppo AuriolaSchool of Pharmacy, University of Eastern Finland, Kuopio FI-70211, Finland.
Minna HolmMental Health Team, Finnish Institute for Health and Welfare, Helsinki FI-00271, Finland.
Kaisla LahdensuoMehiläinen Ltd, Helsinki FI-00260, Finland.
Olli KampmanFaculty of Medicine and Health Technology, Tampere University, Tampere FI-33100, Finland.
Erkki IsometsäDepartment of Psychiatry, University of Helsinki and Helsinki University Hospital, Helsinki FI-00014, Finland.
Tuula KieseppäMental Health Team, Finnish Institute for Health and Welfare, Helsinki FI-00271, Finland.
Jouko LönnqvistMental Health Team, Finnish Institute for Health and Welfare, Helsinki FI-00271, Finland.
Jaana SuvisaariMental Health Team, Finnish Institute for Health and Welfare, Helsinki FI-00271, Finland.ORCID 0000-0001-7167-0990
Jarmo HietalaDepartment of Psychiatry, University of Turku and Turku University Hospital, Turku FI-20700, Finland.
Jari TiihonenDepartment of Forensic Psychiatry, Niuvanniemi Hospital, University of Eastern Finland, Kuopio FI-70240, Finland.
Aarno PalotieInstitute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki FI-00014, Finland.
Ari V Ahola-OlliInstitute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki FI-00014, Finland.
Mikko NiemiDepartment of Clinical Pharmacology, University of Helsinki, Helsinki FI-00014, Finland.ORCID 0000-0003-4550-2189
University of Helsinki · FIUniversity of Eastern Finland · FIBroad Institute · USFinnish Institute for Health and Welfare · FIUniversity of Turku · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Variants in the

Indexed as

Liver-Specific Organic Anion Transporter 1Psychotic DisordersFinlandHEK293 CellsHumansHydroxymethylglutaryl-CoA Reductase InhibitorsRosuvastatin CalciumHydroxymethylglutaryl-CoA Reductase InhibitorsLiver-Specific Organic Anion Transporter 1Rosuvastatin CalciumSLCO1B1 protein, humandrug transporterOATP1B1organic anion transporting polypeptide 1B1pharmacogeneticsSLCO1B1

Identifiers

PMID36779498
PMCPMC9996821
OpenAlexW4320497405

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.